Shanghai Fosun Pharmaceutical : FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021(H SAHRES)

EF001

Disclaimer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arisen from or in reliance upon the whole or any part of the contents of this announcement.

Cash Dividend Announcement for Equity Issuer

Issuer name	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Stock code	02196
Multi-counter stock code and currency	Not applicable
Other related stock code(s) and	Not applicable
name(s)
Title of announcement	FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021
Announcement date	23 March 2022
Status	New announcement
Information relating to the dividend
Dividend type	Final
Dividend nature	Ordinary
For the financial year end	31 December 2021
Reporting period end for the dividend	31 December 2021
declared
Dividend declared	RMB 0.56 per share
Date of shareholders' approval	To be announced
Information relating to Hong Kong share register
Default currency and amount in which	HKD amount to be announced
the dividend will be paid
Exchange rate	To be announced
Ex-dividend date	To be announced
Latest time to lodge transfer documents
for registration with share registrar for	To be announced
determining entitlement to the dividend
Book close period	To be announced
Record date	To be announced
Payment date	To be announced
	Tricor Investor Services Limited
Share registrar and its address	Level 54, Hopewell Centre
	183 Queen's Road East
	Hong Kong

Information relating to withholding tax

Details of withholding tax applied to the dividend declared

Details of withholding tax (including type of shareholders and applicable tax rate) applied to the dividends declared are set out in the table below.

For further details, please refer to the section headed "The Withholding and Payment of Enterprise Income Tax for Non-resident Enterprise Shareholders and of Personal

Page 1 of 2

v 1.1.1

EF001

Income Tax for Individual Shareholders" in the annual results announcement of the Company dated 22 March 2022.

The Company will have no liability in respect of any claims arising from any delay in, or inaccurate determination of the status of the shareholders or any disputes over the mechanism of withholding.

Type of shareholders	Tax rate	Other relevant information
(if any)
Enterprise - non-resident
i.e. registered address	10%	Any shares registered in the
outside PRC	name of the non-individual
		registered shareholders, including
		HKSCC Nominees Limited, other
		nominees or trustees and other
		groups and organizations will be
		treated as being held by non-
		resident enterprise shareholders
		and therefore will be subject to
		the withholding of the enterprise
		income tax at the rate of 10%.
Individual - non-resident
i.e. registered address	10%	When the Company distributes
outside PRC	the 2021 Final Dividend to the
		Hong Kong resident who is the
		individual holders of H shares,
		such dividend will be subject to
		the withholding of individual
		income tax at a rate of 10%.
		However, if otherwise provided by
		tax laws, relevant tax treaties or
		notices, the tax will be withheld in
		accordance with the relevant
		requirements and tax levy and
		administration requirements.
Mainland individual investors	20%	For dividends received by
or securities investment funds	mainland investors from
who have invested in the H		investing in H shares listed on the
shares of the Company		Hong Kong Stock Exchange
through Shanghai Hong Kong		through Shanghai-Hong Kong
Stock Connect or Shenzhen		Stock Connect or Shenzhen-
Hong Kong Stock Connect		Hong Kong Stock Connect, the
		company of such H shares shall
		withhold and pay individual
		income tax at the rate of
		20% on behalf of the investors.

Information relating to listed warrants / convertible securities issued by the issuer

Details of listed warrants / convertible	Not applicable
securities issued by the issuer
Other information

Other information	Not applicable
Directors of the issuer

The executive directors of the Company are Mr. Wu Yifang, Mr. Wang Kexin and Ms. Guan Xiaohui; the non-executive directors of the Company are Mr. Chen Qiyu, Mr. Yao Fang, Mr. Xu Xiaoliang and Mr. Pan Donghui; and the independent non-executive directors of the Company are Ms. Li Ling, Mr. Tang Guliang, Mr. Wang Quandi and Mr. Yu Tze Shan Hailson.

Page 2 of 2

v 1.1.1